Breakdown | |||||
TTM | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
26.59M | 24.01M | 46.66M | 54.03M | 47.00M | 43.01M |
Gross Profit | |||||
11.89M | 10.19M | 21.76M | 26.34M | 23.43M | 22.64M |
EBIT | |||||
-25.37M | -26.72M | -10.99M | 7.49M | -1.21M | 4.64M |
EBITDA | |||||
-22.57M | -26.72M | -7.66M | 933.00K | 3.38M | 7.44M |
Net Income Common Stockholders | |||||
-29.08M | -31.73M | -18.40M | -16.21M | 704.00K | 11.87M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
6.44M | 12.89M | 10.15M | 19.13M | 18.85M | 27.58M |
Total Assets | |||||
11.34M | 53.94M | 49.91M | 71.85M | 90.13M | 71.37M |
Total Debt | |||||
0.00 | 16.30M | 5.29M | 6.14M | 6.90M | 7.48M |
Net Debt | |||||
-6.44M | 11.36M | -3.37M | -6.60M | -6.26M | -15.84M |
Total Liabilities | |||||
1.75M | 36.37M | 16.09M | 21.46M | 24.17M | 22.23M |
Stockholders Equity | |||||
9.59M | 17.56M | 33.81M | 50.39M | 65.96M | 49.14M |
Cash Flow | Free Cash Flow | ||||
-12.90M | -19.64M | -9.83M | 87.00K | 5.94M | 6.78M |
Operating Cash Flow | |||||
-12.78M | -19.45M | -9.59M | 468.00K | 6.15M | 6.92M |
Investing Cash Flow | |||||
3.08M | -8.67M | 5.54M | -89.00K | -15.55M | -3.13M |
Financing Cash Flow | |||||
13.43M | 23.87M | -114.00K | -1.06M | 13.00K | 679.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
58 Neutral | $9.82B | 10.00 | -6.63% | 3.09% | 7.49% | -11.58% | |
52 Neutral | $81.12M | ― | -30.42% | ― | -1.01% | -72.93% | |
43 Neutral | $92.56M | ― | -107.28% | ― | -34.41% | -17.56% | |
43 Neutral | $73.72M | ― | -355.35% | ― | -26.51% | 78.84% | |
41 Neutral | $87.24M | ― | -65.28% | ― | 30.70% | -1.05% |
On January 27, 2025, Genasys Inc. approved its 2025 Equity Incentive Plan, which was later ratified by stockholders on March 17, 2025. This plan allows for various stock and cash-based awards to employees, consultants, and directors, with a total of 6,000,000 shares available for issuance. The plan aims to align the interests of participants with those of stockholders and includes provisions for stock options, restricted stock, and other awards. Additionally, the company held its Annual Meeting of Stockholders on March 17, 2025, where seven directors were elected, and the appointment of Baker Tilly US, LLP as the independent registered public accounting firm was ratified.